Журнал бактериологии и паразитологии

Абстрактный

In-vitro Evaluation of Thymol Derived from Trachyspermum ammi against Acetaminophen Induced Hepatotoxicity Towards Lymphatic Filariasis Therapeutics

Abel Arul Nathan and Anand Setty Balakrishnan*

Individuals with lymphatic filariasis (LF) shows elevated levels of pro-inflammatory cytokines, altered expressions of inflammatory genes and are prone to secondary bacterial infection. Also markers of liver dysfunction were reported to be high with increased filarial infection. Acetaminophen (Paracetamol), an anti-pyretic drug was prescribed to LF individuals along with Diethylcarbamazine and Albendazole to alleviate pain and filarial fever within the therapeutic dosage. It is unclear, whether parasite secreted toxins augments the action of acetaminophen and enhances liver dysfunction. Hence, an agent which can attenuate the acetaminophen toxicity during filarial infection is warranted. Trachyspermum ammi (T. ammi) is the richest source of thymol, reported to have anti-filarial lead molecule. In the present study we evaluated the effects of thymol against acetaminophen induced hepatotoxicity in in-vitro settings. In addition, we examined the synergistic effects of thymol against bacterial infection, free radicals and cytokine production. Our results reveal that acetaminophen induces significant reduction in the viability of WRL-68 liver cells compared to cells without treatment. However, thymol at the same concentration restores the cell viability significantly (p=0.031) by attenuating the toxicity within 24h. Thymol inhibits the expression of Interleukin-6 (p=0.043) and Interleukin-8 (p=0.048) in WRL-68 cells and thereby augments maximum protection to liver cells from inflammatory insults. Calorimetric analysis shows the ability of thymol in scavenging hydrazyl (p=0.004) and hydrogen peroxide (p=0.008) free radicals efficiently. Thus thymol derived from T. ammi may be a good therapeutic agent in reducing the toxicity of acetaminophen, may also aids in LF treatment and management in addition to the existing drugs.